1. U.S. Food and Drug Administration. CLARINEX® (desloratadine) Tablets, Syrup, RediTabsPrescribing Information. Rev 2005/2006. Kenilworth (NJ): Schering Corporation.
2. U.S. Food and Drug Administration. CLARINEX® (desloratadine) TabletsPrescribing Information. 2002 Feb 8.
3. Vuurman EFPM, Rikken GH, Muntjewerff ND, de Halleux F, Ramaekers JG. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol. 2004;60(5):307–13.
4. Scharf M, Berkowitz D. Effects of desloratadine and alcohol coadministration on psychomotor performance. Curr Med Res Opin. 2007;23(2):313–21.
5. Heinzerling L, Mari A, Bergmann K-C, Bresciani M, Burbach GJ, Darsow U, et al. The skin prick testEuropean standards. Clin Transl Allergy. 2013;3:3.
6. Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734–66.
7. Ellis AK, Murrieta-Aguttes M, Lima WT, Salapatek AM, Lee SE, Rabe KF, et al. Allergic rhinitis. Allergy Asthma Clin Immunol. 2024. Online ahead of print.
8. U.S. Food and Drug Administration; Organon. Patient Information: CLARINEX®. [Internet].
9. DailyMed. DesloratadineLabeling (Section 8.2 Lactation). Desloratadine passes into breast milk. [Internet].
10. National Library of Medicine. DesloratadineSummary of Use during Lactation. Drugs and Lactation Database (LactMed). 2021.